Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

معلومة اضافية
- الموضوع:
  AGIOS Pharmaceuticals Inc.; ACUTE myeloid leukemia; PUBLISHING; ISOCITRATE dehydrogenase; HEMATOPOIETIC stem cells; NATURE (Periodical); EPIGENETICS
- نبذة مختصرة :
  The article informs that Agios Pharmaceuticals Inc. has published a new study that provides evidence of the link between a mutated metabolic enzyme and acute myeloid leukemia (AML). The study provides an understanding of the mechanism of isocitrate dehydrogenase (IDH) mediated disease. The article titled "Idh1-R132H mutation increases murine hematopoietic progenitors and alters epigenetics," has been published in the online edition of the journal "Nature" in the July 4, 2012.